Do Hedge Funds Love Karyopharm Therapeutics Inc (KPTI)?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
Karyopharm Therapeutics Inc. (KPTI)
Market is closed
News
- First
- << Previous
- 31 - 34
Looking Ahead To The Karyopharm Therapeutics Inc (KPTI) MM Data
Karyopharm Therapeutics Inc (NASDAQ:KPTI) is set to report an overview of the topline data from its lead multiple myeloma trial on September 6 and markets are rallying in advance of good news.
Do Hedge Funds Love Karyopharm Therapeutics Inc (KPTI)?
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips.
Foresite Capital Management I Reveals 5.6% Position in Karyopharm Therapeutics
Foresite Capital Management I disclosed, in a new filing with the SEC, a new passive stake in Karyopharm Therapeutics Inc (NASDAQ:KPTI), which amasses 5.6% of the company's common stock.
- First
- << Previous
- 31 - 34
Billionaire Hedge Funds
